Browse result page of THPdb

The total number entries retrieved from this search are 80

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1627	ThPPIDTh1138	NameRaxibacumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological/Infectious	BrandRAXIBACUMAB	CompanyGSK	Physical AppearanceSterile, liquid formulation in single-dose vials	Route of AdministartionN.A.	CategoryAnti-Infective Agents and Monoclonal antibodies	TargetProtective antigen
ID1644	ThPPIDTh1147	NameNatalizumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Immunological	BrandTysabri	CompanyBiogen Idec Inc.	Physical AppearanceSterile, colorless, and clear to slightly opalescent concentrate	Route of AdministartionIntravenous infusion	CategoryImmunosuppressive agents	TargetN.A.
ID1653	ThPPIDTh1149	NameRagweed Pollen Extract	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIIa	DiseaseImmunological	BrandRagwitek	CompanyMerck Sharp & Dohme	Physical AppearanceTablets	Route of AdministartionOral route	CategoryN.A.	TargetN.A.
ID1654	ThPPIDTh1150	NameSecukinumab	Peptide SequenceSecukinumab Heavy Ch Full view	Length672	Functional ClassificationIIa	DiseaseImmunological	BrandCosentyx	CompanyNovartis Pharmaceuticals Corporation	Physical AppearanceSterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution.	Route of AdministartionSubcutaneous injection	CategoryInhibitor	TargetIL-17A cytokine
ID1661	ThPPIDTh1153	NameAlefacept	Peptide SequenceHeavy Chain: CFSQQIY Full view	Length705	Functional ClassificationIIa	DiseaseImmunological	BrandAmevive	CompanyAstellas Pharma Inc.	Physical AppearanceSterile, white-to-off-white, preservative-free, lyophilized powder	Route of AdministartionIntramuscular Injection	CategoryDermatologic and Immunosupressive agents	TargetT-cell surface antigen CD2, Complement C1r subcomponent, Complement C1q subcomponent subunit A, B, C, Low affinity immunoglobulin gamma Fc region receptor III-A,III-B, II-a, II-b, II-c
ID1667	ThPPIDTh1158	NameAprotinin	Peptide SequenceRPDFCLEPPYTGPCKARIIR Full view	Length58	Functional ClassificationIIa	DiseaseImmunological	BrandTrasylol	CompanyBayer Pharmaceuticals	Physical AppearanceClear, colorless, sterile isotonic solution	Route of AdministartionIntravenous administration	CategoryN.A.	TargetTrypsin-1, Chymotrypsinogen B, Plasminogen, Kallikrein-!
ID1772	ThPPIDTh1187	NameHuman Rho(D) immune globulin	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandHyp Rho D Inj 16.5%	CompanyCutter Med & Biol, Division Of Miles Canada Ltd.	Physical Appearanceliquid	Route of AdministartionIntramuscular	CategoryNA	TargetNA
ID1773	ThPPIDTh1187	NameHuman Rho(D) immune globulin	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandHyperrho S/d Full Dose	CompanyGRIFOLS USA, LLC	Physical AppearanceSoution	Route of AdministartionIntramuscular	CategoryNA	TargetNA
ID1774	ThPPIDTh1187	NameHuman Rho(D) immune globulin	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandHyperrho S/d Mini-dose	CompanyGRIFOLS USA, LLC	Physical AppearanceSolution	Route of AdministartionIntramuscular	CategoryNA	TargetNA
ID1775	ThPPIDTh1187	NameHuman Rho(D) immune globulin	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandMicrhogam Ultra-filtered Plus	CompanyKedrion Melville, Inc.	Physical AppearanceInjection, Solution	Route of AdministartionIntramuscular	CategoryNA	TargetNA
ID1776	ThPPIDTh1187	NameHuman Rho(D) immune globulin	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandRhogam Ultra-filtered Plus	CompanyKedrion Melville, Inc.	Physical AppearanceInjection, Solution	Route of AdministartionIntramuscular	CategoryNA	TargetNA
ID1777	ThPPIDTh1187	NameHuman Rho(D) immune globulin	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandRhophylac	CompanyCsl Behring Ag	Physical AppearanceSolution	Route of AdministartionIntramuscular; Intravenous	CategoryNA	TargetNA
ID1778	ThPPIDTh1187	NameHuman Rho(D) immune globulin	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandWinrho Sdf	CompanyAptevo Biotherapeutics Llc	Physical Appearancekit	Route of AdministartionIntramuscular; Intravenous	CategoryNA	TargetNA
ID1779	ThPPIDTh1187	NameHuman Rho(D) immune globulin	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandWinrho Sdf (liquid Formulation)	CompanyAptevo Biotherapeutics Llc	Physical Appearanceliquid	Route of AdministartionIntramuscular; Intravenous	CategoryNA	TargetNA
ID1785	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandBivigam	CompanyKedrion Biopharma, Inc.	Physical AppearanceInjection, Solution	Route of AdministartionIntravenous	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1786	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandBivigam	CompanyBiotest Pharmaceuticals Corporation	Physical AppearanceInjection, Solution	Route of AdministartionIntravenous	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1788	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandCarimune Nanofiltered	CompanyCsl Behring Ag	Physical AppearanceInjection, Powder, Lyophilized, for Solution	Route of AdministartionIntravenous	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1791	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandFlebogamma Dif	CompanyGRIFOLS USA, LLC	Physical AppearanceInjection, Solution	Route of AdministartionIntravenous	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1793	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandGamastan	CompanyCutter Med & Biol, Division Of Miles Canada Ltd.	Physical Appearanceliquid	Route of AdministartionIntramuscular	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1794	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandGamastan S/d	CompanyGRIFOLS USA, LLC	Physical AppearanceInjection	Route of AdministartionIntramuscular	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1795	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandHyqvia	CompanyBaxalta Us Inc.	Physical AppearanceLiquid	Route of AdministartionIntravenous infusion	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1796	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandIveegam Immuno 5000mg (iv)	CompanyBaxter Ag	Physical AppearanceNA	Route of AdministartionNA	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1797	ThPPIDTh1191	NameVedolizumab	Peptide SequenceHeavy Chain Sequence Full view	Length716	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandEntyvio	CompanyTakeda Pharmaceuticals America, Inc.	Physical AppearanceInjection, Powder, Lyophilized, for Solution	Route of AdministartionIntravenous	CategoryImmunosupressive agent, Antineoplastic agent	TargetIntegrin alpha-4, Integrin beta-7
ID1802	ThPPIDTh1196	NameSiltuximab	Peptide SequenceHeavy Chain Sequence Full view	Length708	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandSylvant	CompanyJanssen Inc	Physical AppearanceLyophilized Powder	Route of AdministartionIntravenous infusion	CategoryAntineoplastic and Immunomodulating Agents, Immunosuppressive Agents	TargetInterleukin-6
ID1826	ThPPIDTh1216	NameAnthrax immune globulin human	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandANTHRASIL	CompanyCangene Corporation	Physical AppearanceLiquid	Route of AdministartionIntravenous	CategoryPlasma derivative	TargetProtective antigen
ID1828	ThPPIDTh1218	NameAnti-thymocyte Globulin (Equine)	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandATGAM	CompanyNA	Physical Appearance Solid	Route of Administartion Intravenous	CategoryAntibody	TargetNA
ID1829	ThPPIDTh1219	NameAnti-thymocyte Globulin (Rabbit)	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandATG-Fresenius	CompanyGenzyme Inc.	Physical AppearanceConcentrate for solution for infusion.	Route of Administartion Intravenous	CategoryAntibody	TargetT-cell surface glycoprotein CD1a, Major histocompatibility complex class I-related gene protein, Integrin alpha-L, T-lymphocyte activation antigen CD86, Low affinity immunoglobulin gamma Fc region receptor II-b, T-cell surface glycoprotein CD4, Integrin beta-1, Integrin alpha-V, Integrin beta-3
ID1830	ThPPIDTh1220	NameBrodalumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandSiliq	CompanyNA	Physical Appearancesterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution	Route of AdministartionSubcutaneous	CategoryAntineoplastic and Immunomodulating Agents	Target Interleukin 17 receptor A
ID1832	ThPPIDTh1222	NameCanakinumab	Peptide SequenceH-GAMMA-1 Chain: QVQ Full view	Length842	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandIlaris	CompanyNovartis	Physical AppearanceLyphilized powder	Route of AdministartionSubcutaneous	CategoryAntineoplastic and Immunomodulating Agents	TargetInterleukin-1 beta
ID1844	ThPPIDTh1232	NameLenograstim	Peptide SequenceNA Full view	Length0	Functional ClassificationIb	DiseaseImmunological Disorders	BrandGranocyte	CompanyNA	Physical AppearanceSolid	Route of AdministartionSubcutaneous or Intravenous	CategoryAntineoplastic and Immunomodulating Agents	TargetGranulocyte colony-stimulating factor receptor